PTGS2 and neoplasm: However, despite their side effects, these molecules possess potent anti-tumor properties and thus it has been suggested that modifying the chemical structure of COX-2 inhibitors may represent an appealing approach to preserve their anti-tumor effects and impair their binding to COX-2 catalytic domain, which are responsible for most deleterious effects.